Price $548.28 |
Market Cap
496.62B
|
Sector Health Care |
Div. Growth
13.80%
|
|
P/E
23.0
|
P/B
6.0
|
P/S
1.37
|
Dividend %
1.40%
|
|
P/CF
29.1
|
P/FCF
15.7
|
Op. Cash Flow
41.38M
|
FCF
33.7
|
|
Op. Margin
8.50%
|
Net Margin
5.90%
|
ROE
26.70%
|
ROI
16.80%
|
|
ROA
8.00%
|
EPS Growth
16.50%
|
Current Ratio
-
|
Debt/Equity
70.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, In (CPIX) | $1.68 | - | - | 28.7M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.15 | - | - | 4.1M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $121.45 | - | - | 8.13B | Strong Buy |
| Journey Medical Corp (DERM) | $4.97 | - | - | 43.3M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.37 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
